Browsing Tag
ORKA-001
1 post
Oruka Therapeutics stock surges as ORKA-001 psoriasis trial success puts $1.1bn biotech strategy to the test
Oruka Therapeutics stock rallies after ORKA-001 delivers 61% psoriasis clearance. Explore its $1.1B cash position and Phase 3 growth potential.